MedCellPress Profile Banner
Med by Cell Press Profile
Med by Cell Press

@MedCellPress

Followers
13K
Following
200
Media
247
Statuses
920

Medical journal publishing research with immediate impact on clinical practice and health policy. This account is not monitored, and content is automated.

Joined December 2019
Don't wanna be here? Send us removal request.
@MedCellPress
Med by Cell Press
3 months
We are turning this account into a fully automated page. To learn more of what’s going on in our journal, follow us on LinkedIn:
Tweet media one
1
0
0
@MedCellPress
Med by Cell Press
5 days
Online Now: Conformational ligand-directed targeting of calcium-dependent receptors in acute trauma
0
0
0
@MedCellPress
Med by Cell Press
10 days
Online Now: Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancers
0
0
0
@MedCellPress
Med by Cell Press
14 days
We were so excited to see the innovative science at @KeystoneSymp's Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies! Access the content now on-demand: #KSNeuroDegen25
Tweet media one
0
2
2
@MedCellPress
Med by Cell Press
14 days
@MedCellPress Editor’s Choice.Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype.
Tweet media one
0
0
0
@MedCellPress
Med by Cell Press
17 days
Online Now: A phase 3, randomized trial to evaluate lot-to-lot consistency of V116, an adult-specific pneumococcal conjugate vaccine (STRIDE-4)
0
0
1
@MedCellPress
Med by Cell Press
22 days
We were so excited to see the innovative science at @KeystoneSymp's Vaccinology: Horizons Across Disease, Demography and Technology! Access the content now on-demand: #KSVaccines25
Tweet media one
0
2
2
@MedCellPress
Med by Cell Press
27 days
Online Now: Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer’s disease
0
0
0
@MedCellPress
Med by Cell Press
1 month
Online Now: Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial
0
0
0
@MedCellPress
Med by Cell Press
1 month
Online Now: Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study
0
1
3
@MedCellPress
Med by Cell Press
1 month
Online Now: Donor composition and fiber promote strain engraftment in a randomized controlled trial of fecal microbiota transplant for ulcerative colitis
0
0
0
@MedCellPress
Med by Cell Press
1 month
Online Now: Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
0
0
0
@MedCellPress
Med by Cell Press
1 month
Online Now: Oral lamivudine in diabetic macular edema: A randomized, double-blind, placebo-controlled clinical trial
0
0
0
@MedCellPress
Med by Cell Press
1 month
Online Now: Epidural electrical stimulation facilitates motor recovery in spinal cord injury involving the conus medullaris: A case study
0
0
0
@MedCellPress
Med by Cell Press
1 month
Online Now: Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy
0
2
3
@MedCellPress
Med by Cell Press
1 month
Online Now: Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality
0
0
1
@MedCellPress
Med by Cell Press
2 months
Online Now: Audiological characteristics following gene therapy in patients with autosomal recessive deafness 9
0
0
0
@MedCellPress
Med by Cell Press
2 months
Online Now: DiabetesLiver score: A non-invasive algorithm for advanced liver fibrosis and liver-related outcomes in type 2 diabetes mellitus population
0
0
0
@MedCellPress
Med by Cell Press
2 months
Online Now: Advances in TIL therapy: Expanding the horizons beyond melanoma
0
0
0
@MedCellPress
Med by Cell Press
2 months
Online Now: HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial
0
0
0
@MedCellPress
Med by Cell Press
2 months
Online Now: Emerging trends in clinical allogeneic CAR cell therapy
0
0
1